Hazar, V. Et Al. 2005. Clinical importance of circulating and cellular expression levels of Fas and Fas ligand in pediatric patients with lymphoproliferative malignancies. PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.22, no.3 , 247-256.

Hazar, V., Berber, Z., Pestereli, E., Coskun, M., Yesilipek, A., Karpuzoglu, G., ... Yegin, O.(2005). Clinical importance of circulating and cellular expression levels of Fas and Fas ligand in pediatric patients with lymphoproliferative malignancies. PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.22, no.3, 247-256.

Hazar, V Et Al. "Clinical importance of circulating and cellular expression levels of Fas and Fas ligand in pediatric patients with lymphoproliferative malignancies," PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.22, no.3, 247-256, 2005

Hazar, V Et Al. "Clinical importance of circulating and cellular expression levels of Fas and Fas ligand in pediatric patients with lymphoproliferative malignancies." PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.22, no.3, pp.247-256, 2005

Hazar, V. Et Al. (2005) . "Clinical importance of circulating and cellular expression levels of Fas and Fas ligand in pediatric patients with lymphoproliferative malignancies." PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.22, no.3, pp.247-256.

@article{article, author={V Hazar Et Al. }, title={Clinical importance of circulating and cellular expression levels of Fas and Fas ligand in pediatric patients with lymphoproliferative malignancies}, journal={PEDIATRIC HEMATOLOGY AND ONCOLOGY}, year=2005, pages={247-256} }